The industry is entering “the golden era for biosimilars,” Amneal co-CEO Chirag Patel said Wednesday morning as he explained the motivation for his company’s $1.1 billion acquisition of Kashiv BioSciences.
The industry is entering “the golden era for biosimilars,” Amneal co-CEO Chirag Patel said Wednesday morning as he explained the motivation for his company’s $1.1 billion acquisition of Kashiv BioSciences.
Ever get so mad you could just… run a mile? Anger can be fiery fuel for a serious sweat session — and that exercise, in turn, …
A bid by hard-line conservatives to pass a measure banning the Federal Reserve from issuing a central bank digital currency (CBDC) fell short, but the fight …
The World Health Organization says that a suspected hantavirus outbreak on a cruise ship in the Atlantic Ocean has killed three people and sickened at least …
Homeland Security Secretary Markwayne Mullin on Sunday said the Cybersecurity and Infrastructure Security Agency (CISA) lost about 1,100 employees over the course of the partial government …